Want to join the conversation?
$CGNT said it signed a deal with Accelmed Growth Partners, under which Accelmed would buy $25MM of $CGNT common stock at $1.55 per share, a 29% premium over closing price on Sept. 6. Company will use the proceeds for working capital as well as to implement business development strategy to acquire growth technologies in the urology market.
Looking forward to the first $TSLA earnings after SolarCity acquisition.
What will be an ideal EPS range for $PZZA in its earnings today?